688117.SS Stock Analysis
68
Uncovered
Cheng Du Sheng Nuo Biotec Co Ltd is uncovered by Eyestock quantitative analysis.
Cheng Du Sheng Nuo Biotec Co., Ltd. engages in research, development, production, customized manufacturing, and sale of polypeptide generic drug raw materials and preparation products. The company is headquartered in Chengdu, Sichuan and currently employs 680 full-time employees. The company went IPO on 2021-06-03. The firm's products target areas including immunology, digestive tract, antivirus, gynecology, diabetes, cardio-cerebrovascular, rare diseases, orthopedics and other fields. The firm is also engaged in customized peptide production services for customers, customized production services for peptide APIs and preparations, and technology transfer services for peptide drug production. The firm also provides small-molecule chemical drug Levosimendan preparations on behalf of processing, Levosimendan bulk drug production and export sales business.